Lubna Therachiyil
Doha, DA, Qatar
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Advancements in computational tools in proteomics: Revolutionizing data analysis.
Journal: International review of cell and molecular biology
Published: May 26, 2026
Longitudinal Plasma Proteome of Pfizer/BNT162b2 Pre- and Postbooster Vaccinated Healthy Individuals Reveals Distinct Protein Profiles upon SARS-CoV-2 Spike Protein Stimulation.
Journal: Journal of proteome research
Published: February 03, 2026
Comparative proteomic analysis of colorectal cancer stem cells reveals potential biomarkers and altered pathways.
Journal: Frontiers in molecular biosciences
Published: February 01, 2026
Proteomics-Driven Cancer Biomarkers for Early Detection and Targeted Therapy: Insights from the Middle East.
Journal: Journal of proteome research
Published: December 12, 2025
Protein misfolding and cancer - proteomics as an approach for biomarker discovery.
Journal: Advances in protein chemistry and structural biology
Published: November 27, 2025
GADD45: a crucial component of the DNA damage response and a potential cancer therapeutic target.
Journal: Expert opinion on therapeutic targets
Published: November 12, 2025
Microdialysis-based metabolomic and proteomic profiling reveals signature variations for disease severity in psoriasis.
Journal: The Journal of investigative dermatology
Published: September 25, 2025
Claudins in ovarian cancer: emerging biomarkers and therapeutic targets.
Journal: Tissue barriers
Published: August 13, 2025
SKP2 E3 ligase in urological malignancies: a critical regulator of the cell cycle and therapeutic target.
Journal: Cell cycle (Georgetown, Tex.)
Published: July 03, 2025
The role of immune checkpoints in modulating cancer stem cells anti-tumor immune responses: implications and perspectives in cancer therapy.
Journal: Journal of experimental & clinical cancer research : CR
Published: April 28, 2025
PTUPB, a soluble epoxide hydrolase/cyclooxygenase‑2 dual inhibitor, reduces endothelial‑to‑mesenchymal transition and improves doxorubicin‑induced vascular and cardiac toxicity.
Journal: Molecular medicine reports
Published: March 18, 2025
Oncoproteins E6/E7 of the human papillomavirus types 16 & 18 synergize in modulating oncogenes and tumor suppressor proteins in colorectal cancer.
Journal: Expert review of proteomics
Published: January 16, 2025
Last Updated: 09/26/2026